China's Bio-Thera gets approval for Humira biosimilar

China's Bio-Thera Solutions Ltd has won a regulatory approval for its version of AbbVie Inc's blockbuster rheumatoid arthritis treatment Humira, paving the way for the first such biosimilar to enter the world's second-largest drug market.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news